Monitor the company's next quarterly filing for signs of continued revenue decline and any progress in remedying its material weaknesses in internal controls. The significant increase in R&D spending without a corresponding revenue increase is a key risk factor for future profitability.
Price Chart
Executive Summary
Baird Medical Investment Holdings Ltd reported a significant decline in revenue and a large net loss for 2025, driven by a 39% drop in sales of its core microwave ablation devices. This follows a pattern of deteriorating financials, with a material weakness in internal controls over financial reporting and a recent auditor change, raising concerns about governance and future performance.
Key Facts
- Revenue declined by 39.2% from $37.0 million in 2024 to $22.5 million in 2025.
- The company reported a net loss of $27.5 million in 2025, a sharp reversal from a $12.6 million net income in 2024.
- Gross profit margin decreased from 88.2% in 2024 to 83.8% in 2025.
- Research and development expenses surged from $6.2 million in 2024 to $20.1 million in 2025.
- The company has a material weakness in its internal control over financial reporting, specifically a lack of sufficient accounting personnel with U.S. GAAP expertise.
- The company changed its auditor in February 2026, from Kreit & Chiu to Guangdong Prouden CPAs.
Financial Impact
A significant decline in revenue and a swing from net income to a substantial net loss of $27.5 million.
Risk Factors
- The company's deteriorating financial performance and large net loss could lead to a loss of investor confidence.
- The material weakness in internal controls raises the risk of future financial misstatements and potential regulatory scrutiny.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 20-F Filing (Primary) | 0001104659-26-048641 |
| Document: bdmd-20251231xex4d11.htm | 0001104659-26-048641 |
| Document: bdmd-20251231xex4d10.htm | 0001104659-26-048641 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers